Skip to content

Analgesic efficacy of diluted nitrous oxide on patients with maxillofacial trauma

Analgesic efficacy of diluted nitrous oxide on patients with maxillofacial trauma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600131282
Enrollment
Unknown
Registered
2026-08-31
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maxillofacial trauma

Interventions

Sponsors

The No.960 hospital of PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Willingness to participate in the trial and provision of written informed consent; 2. Age >= 18 years; 3. Patients with maxillofacial trauma requiring local procedures such as wound cleaning, dressing changes, or suture removal; 4. Procedures expected or found to be associated with moderate-to-severe pain (VAS >= 4).

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to nitrous oxide (acute upper respiratory tract infection, chronic obstructive pulmonary disease, pneumothorax, alveolar lungs, air embolism, bowel obstruction, severe sleep apnoea syndrome, epilepsy, claustrophobia or nasal mask intolerance, pregnancy, vitamin B12 deficiency, alcoholism, disease involving ear, nose, larynx, such as otitis media or sinusitis); 2. Polytrauma; 3. Patients with severe mental illness or impaired consciousness preventing accurate pain reporting; 4. Patients with a history of drug dependence or abuse.

Design outcomes

Primary

MeasureTime frame
Pain score;

Secondary

MeasureTime frame
anxiety score;Vital signs;Side effects;Satisfaction;Acceptance;

Countries

China

Contacts

Public ContactLu Tang

The 960th Hospital of PLA

tanglu_office@163.com+86 150 6400 3655

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026